Lone L. Hansen

491 citations
9 papers · 372 indexed · h-index 8
Topics
Antibiotics Pharmacokinetics and Efficacy (3 papers)Pharmacogenetics and Drug Metabolism (3 papers)Cancer therapeutics and mechanisms (2 papers)
Partner nations
DenmarkSwedenIsrael

In The Last Decade

Lone L. Hansen

9 papers receiving 353 citations

Peers

Lone L. Hansen
Comparison fields: 5 of 81
  • Molecular Biology 136
  • Physiology 103
  • Pharmacology 102
  • Oncology 57
  • Endocrinology, Diabetes and Metabolism 49
Replace Juan A. Monti with:
Juan A. Monti Argentina
Adrian Davies United Kingdom
Kwazi Gabuza South Africa
Jiong Yan United States
Irina G. Kessova United States
Jia Lv China
MA Robin France
Rose K. Wang United States
Zhuo-ming Li China
Wataru Kishimoto Japan
Lone L. Hansen relative to Juan A. Monti Argentina Juan A. Monti's profile →
Citations per field
00.5×1.5×
Juan A. Monti · 1×
Citations per year

Countries citing papers authored by Lone L. Hansen

Since Specialization
Citations

This map shows the geographic impact of Lone L. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lone L. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lone L. Hansen more than expected).

Fields of papers citing papers by Lone L. Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lone L. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lone L. Hansen. The network helps show where Lone L. Hansen may publish in the future.

Co-authorship network of co-authors of Lone L. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Lone L. Hansen. A scholar is included among the top collaborators of Lone L. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lone L. Hansen. Lone L. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 6
2 73
3 19
4 18
5 21
6 146
7 47
8 24
9 18

About Lone L. Hansen

Lone L. Hansen is a scholar working on Pharmacology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 9 papers that have together received 372 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Pharmacology (102 citations), Physiology (103 citations) and Biochemistry (28 citations). Lone L. Hansen has collaborated with scholars based in Denmark, Sweden and Israel. Frequent co-authors include Kim Brøsen, Grith Skytte Olsen, Anna K. Busch, Yukio Ikeda, Per Damkier, Luitgard Mosthaf, John Larsen, Ehud Ziv, Bo F. Hansen and Eleazar Shafrir. Their work appears in journals such as Journal of Biological Chemistry, Diabetes and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026